News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
5,708 Results
Type
Article (232)
Company Profile (2)
Press Release (5474)
Section
Business (1741)
Career Advice (10)
Deals (252)
Drug Delivery (1)
Drug Development (490)
FDA (124)
Job Trends (131)
News (2679)
Policy (220)
Tag
Academia (35)
Accelerated approval (1)
Alliances (387)
ALS (1)
Alzheimer's disease (3)
Antibody-drug conjugate (ADC) (1)
Approvals (129)
Artificial intelligence (7)
Bankruptcy (4)
Best Places to Work (108)
Biotechnology (1)
Brain cancer (1)
Cancer (29)
Cardiovascular disease (5)
Career advice (7)
CAR-T (1)
Cell therapy (4)
Clinical research (430)
Collaboration (14)
Complete response letters (1)
COVID-19 (34)
CRISPR (3)
C-suite (8)
Cystic fibrosis (1)
Data (57)
Depression (2)
Diabetes (3)
Diagnostics (35)
Digital health (1)
Drug discovery (2)
Drug pricing (2)
Duchenne muscular dystrophy (2)
Earnings (530)
Editorial (1)
Events (772)
Executive appointments (6)
FDA (149)
Funding (7)
Gene editing (3)
Gene therapy (6)
GLP-1 (6)
Government (29)
Guidances (1)
Healthcare (161)
HIV (1)
Infectious disease (37)
Influenza (1)
Intellectual property (3)
Interviews (3)
IPO (97)
IRA (1)
Job creations (26)
Job search strategy (7)
Layoffs (1)
Legal (75)
Lung cancer (1)
Lymphoma (9)
Machine learning (2)
Manufacturing (5)
MASH (5)
Medical device (132)
Medtech (133)
Mergers & acquisitions (173)
Metabolic disorders (10)
Multiple sclerosis (1)
Neurodegenerative disease (3)
Neuroscience (17)
NextGen: Class of 2026 (64)
Non-profit (89)
Now hiring (1)
Obesity (2)
Ovarian cancer (1)
Pain (2)
Pancreatic cancer (1)
Parkinson's disease (2)
Patents (9)
Patient recruitment (2)
People (726)
Phase 1 (112)
Phase 2 (189)
Phase 3 (153)
Pipeline (36)
Policy (3)
Postmarket research (24)
Preclinical (52)
Rare diseases (1)
Real estate (59)
Regulatory (156)
Research institute (59)
Resumes & cover letters (1)
RSV (1)
Schizophrenia (1)
Startups (40)
Supply chain (1)
Vaccines (9)
Weight loss (1)
Women's health (1)
Date
Last 7 days (4)
Last 30 days (9)
Last 365 days (238)
2026 (11)
2025 (250)
2024 (284)
2023 (353)
2022 (366)
2021 (392)
2020 (461)
2019 (384)
2018 (293)
2017 (195)
2016 (238)
2015 (257)
2014 (231)
2013 (221)
2012 (269)
2011 (258)
2010 (236)
Location
Africa (8)
Arizona (1)
Asia (259)
Australia (53)
California (40)
Canada (48)
China (2)
Connecticut (3)
Europe (474)
Florida (3)
Illinois (1)
India (2)
Indiana (1)
Maryland (8)
Massachusetts (69)
Michigan (1)
Minnesota (3)
New Jersey (70)
New York (51)
North Carolina (11)
Northern California (17)
Oregon (1)
Pennsylvania (11)
South America (3)
Southern California (17)
Texas (8)
United States (322)
Utah (2)
Virginia (40)
Washington D.C. (2)
Washington State (3)
5,708 Results for "allen institute.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sun Pharma Announces Jeremy Allen as Vice President, Corporate Affairs for North America
October 23, 2025
·
3 min read
Press Releases
Zephyr AI Appoints Watson Pharmaceuticals Founder Dr. Allen Chao as Chief Executive Officer
August 26, 2025
·
3 min read
Press Releases
Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics
July 31, 2025
·
3 min read
National Science Foundation Awards Booz Allen $419M Technology Modernization Contract
Booz Allen Hamilton announced it was awarded a seven-year, $419 million contract with the National Science Foundation for Information Technology Mission Application Support.
July 1, 2024
·
5 min read
BioForest
Allen Institute joins the Weill Neurohub
The Allen Institute has officially become the newest member of the Weill Neurohub, a collaborative research network advancing treatments for neurological diseases.
March 6, 2024
·
5 min read
BioForest
Allen Institute for Cell Science launches first disease-specific cell line collections
The Allen Institute for Cell Science unveiled a set of tools to accelerate research into hypertrophic cardiomyopathy, the most common genetic heart condition in the world: six new cell line collections, each carrying a different mutation associated with HCM.
June 4, 2024
·
5 min read
Business
Zenas BioPharma Appoints Patricia Allen to its Board of Directors
Zenas BioPharma today announced the appointment of Patricia Allen to its Board of Directors, on which she also will serve as Chairperson of the Audit Committee.
March 6, 2024
·
2 min read
Business
MedPharm, Ltd. Appoints Lynn Allen as Chief Executive Officer
MedPharm, a global topical and transdermal CDMO, announced that Lynn Allen has been named Chief Executive Officer, effective January 1, 2024.
January 18, 2024
·
2 min read
Business
The Paul G. Allen Family Foundation awards $10.5 million to new Allen Distinguished Investigators
Uncovering biological properties of extracellular vesicles, which play a vital role in how cells communicate, and understanding how sex hormones drive behavior and development are two areas that the new cohorts of Allen Distinguished Investigators will research, thanks to over $10 million in funding from the Paul G.
November 21, 2023
·
10 min read
Business
Nanoscope Therapeutics Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment of Allen C. Ho, MD, as Chief Medical Advisor
Nanoscope Therapeutics, Inc. announced today the appointment of Allen C. Ho , MD, FACS, FASRS, as Chief Medical Advisor, where he will help define the strategy of developing the gene mutation-agnostic therapies.
April 25, 2024
·
3 min read
1 of 571
Next
